See more : ToughBuilt Industries, Inc. (TBLT) Income Statement Analysis – Financial Results
Complete financial analysis of Mycotopia Therapies, Inc. (TPIA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mycotopia Therapies, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Voyager Therapeutics, Inc. (VYGR) Income Statement Analysis – Financial Results
- Musgrave Minerals Limited (MGVMF) Income Statement Analysis – Financial Results
- Indigo Paints Limited (INDIGOPNTS.NS) Income Statement Analysis – Financial Results
- Artroniq Berhad (0038.KL) Income Statement Analysis – Financial Results
- Capital Power Corporation (CPX-PI.TO) Income Statement Analysis – Financial Results
Mycotopia Therapies, Inc. (TPIA)
About Mycotopia Therapies, Inc.
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.87M | 12.82M |
| Cost of Revenue | 61.22K | 1.00K | 249.00 | 0.00 | 323.00 | 672.00 | 14.52M | 12.53M |
| Gross Profit | -61.22K | -1.00K | -249.00 | 0.00 | -323.00 | -672.00 | 349.81K | 284.10K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.35% | 2.22% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 616.72K | 1.88M | 2.67M | 159.45K | 242.87K | 177.56K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 616.72K | 1.88M | 2.67M | 159.45K | 242.87K | 177.56K | 174.56K | 194.12K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 25.00K | 8.84K | -363.63K | 0.00 | 0.00 |
| Operating Expenses | 616.72K | 1.88M | 2.67M | 159.45K | 251.72K | 186.07K | 174.56K | 194.12K |
| Cost & Expenses | 616.72K | 1.88M | 2.67M | 159.45K | 251.72K | 186.07K | 14.70M | 12.73M |
| Interest Income | 0.00 | 875.53 | 151.62 | 2.21K | 16.25K | 15.92K | 5.96K | 1.44K |
| Interest Expense | 0.00 | 875.53K | 151.62K | 1.81K | 8.00 | 119.00 | 22.00 | 8.00 |
| Depreciation & Amortization | 61.22K | 1.00K | 249.00 | 548.00 | 323.00 | 672.00 | 897.00 | 1.36K |
| EBITDA | -555.51K | -1.74M | -4.99M | -13.68K | -252.89K | -169.48K | 205.50K | 110.60K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.18% | 0.71% |
| Operating Income | -616.72K | -1.88M | -2.67M | -159.45K | -251.72K | -186.07K | 175.24K | 89.98K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.18% | 0.70% |
| Total Other Income/Expenses | -564.62K | -875.53K | -151.62K | -1.81K | -1.50K | 15.80K | 29.34K | 19.24K |
| Income Before Tax | -1.18M | -2.75M | -2.82M | -157.24K | -253.22K | -170.28K | 204.59K | 109.22K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.38% | 0.85% |
| Income Tax Expense | 0.00 | 875.53K | 151.62K | 84.97K | -235.77K | 15.92K | 74.77K | 36.87K |
| Net Income | -1.18M | -3.63M | -2.97M | -242.21K | -17.46K | 61.20K | 129.82K | 72.35K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.87% | 0.56% |
| EPS | -0.08 | -0.25 | -0.22 | -0.02 | 0.00 | 0.00 | 0.01 | 0.01 |
| EPS Diluted | -0.08 | -0.25 | -0.22 | -0.02 | 0.00 | 0.00 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 14.88M | 14.45M | 13.41M | 12.43M | 12.43M | 12.85M | 12.15M | 12.15M |
| Weighted Avg Shares Out (Dil) | 14.88M | 14.45M | 13.41M | 12.43M | 12.43M | 12.85M | 12.15M | 12.15M |
Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million
Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The Transactions
Source: https://incomestatements.info
Category: Stock Reports